BNGO - Bionano Genomics Inc

1.12
-0.010   -0.893%

Share volume: 137,703
Last Updated: 03-06-2026
Measuring And Control Equipment/Lab Analytical Instruments: -0.08%

PREVIOUS CLOSE
CHG
CHG%
$1.13
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
28%
Profitability 33%
Dept financing 25%
Liquidity 25%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.75%
1 Month
-2.61%
3 Months
-31.71%
6 Months
-73.71%
1 Year
-72.55%
2 Year
-2.61%
Key data
Stock price
$1.12
P/E Ratio 
0.00
DAY RANGE
$1.08 - $1.12
EPS 
-$5.25
52 WEEK RANGE
$1.06 - $5.50
52 WEEK CHANGE
-$69.85
MARKET CAP 
8.005 M
YIELD 
N/A
SHARES OUTSTANDING 
10.176 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
01-27-2025
NEXT EARNINGS DATE
05-07-2025
BETA 
2.66
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$117,574
AVERAGE 30 VOLUME 
$143,392
Company detail
CEO: Robert E. Holmlin
Region: US
Website: bionanogenomics.com
Employees: 300
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping. NxClinical offers one system for analysis and interpretation of genomic variants from microarray and next-generation sequencing data for cytogenetics and molecular genetics.

Recent news